Sares-Regis buys 29 acres at Conejo Spectrum in Thousand Oaks
The Sares-Regis Group bought 29 acres of land at the Conejo Spectrum Business Park in Thousand Oaks with plans to build out industrial buildings, according to Colliers International. The property management company with an office in Goleta partnered with an investment firm to purchase the land near Rancho Conejo Boulevard and Conejo Spectrum Drive for Read More →
Read More →Here’s a wish list for leadership in 2017
By Ritch Eich America appears to be continuing down the same divided path that plagued our nation in 2016. We desperately need enlightened leadership in the New Year. Here is my Top 10 “Wish List” for elected officials and organizational leaders who are in positions to move our country forward. 1. Assemble world leadership: Focus Read More →
Read More →
Orfalea price cut signals soft Ventura County office market
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Patent ruling in favor of Amgen has shares skyrocketing
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Read More →Thousand Oaks makes interim city manager permanent
After serving as interim city manager for Thousand Oaks since July 5, 2016, Andrew Powers was brought on permanently Jan. 10 in a special meeting of the Thousand Oaks City Council. Powers had previously served as assistant city manager and in community and media relations roles for Ventura and Raleigh, N.C. He received his bachelor’s Read More →
Read More →Amgen updates agreement with DaVita for dialysis treatment
Thousand Oaks biotech company Amgen entered into a six-year supply agreement with DaVita for dialysis treatments, the company announced on Jan. 9. Under the terms of the new agreement, Amgen will supply DaVita with Epogen and Aranesp for agents to stimulate red blood cells in dialysis treatment in the United States and Puerto Rico. The Read More →
Read More →Amgen partners with Immatics Biotechnologies to develop cancer drugs
Thousand Oaks biotech company Amgen formed a potential $500 million partnership with Immatics Biotechnologies GmbH to research and develop next-generation, T-cell engaging bispecific immunotherapies targeting multiple cancers, the company announced on Jan. 9. Under the terms of the agreement, Immatics will receive $30 million upfront and can receive more than $500 million in development, regulatory Read More →
Read More →
Sponsored content:
2015-2016 Giving Guide
